ZVIA Short Interest Plunges 63% as Insiders Sell

Forward-Looking Analysis

Analysts maintain a consensus "Hold" rating for Zevia PBC (ZVIA), derived from three buy, two hold, and one sell recommendation, resulting in an average rating score of 2.33. The prevailing consensus price target stands at $4.43, implying a significant upside potential of approximately 164.2% from the current trading price of $1.68. Research coverage remains limited, with only one research report published in the past 90 days, indicating sparse institutional attention. Regarding earnings trajectory, projections indicate continued earnings growth for the coming fiscal period. Specifically, the company is expected to narrow its losses, with earnings per share (EPS) forecast to improve from ($0.10) to ($0.06) per share. Valuation metrics present a mixed picture; the Price to Book (P/B) ratio is recorded at 3.56. Analysts note that a P/B ratio exceeding 3.0 suggests the stock may be overvalued relative to its net assets and liabilities. Despite the negative earnings trajectory, the projected improvement in EPS serves as the primary quantitative metric for the upcoming quarter's performance expectations among the limited analyst community covering the stock.

Historical Performance Review

Zevia reported mixed results for the 2026Q1 period, generating total revenue of $46.09 million. The company posted a gross profit of $22.29 million, reflecting a gross margin of approximately 48.4%. However, profitability remained elusive as the firm recorded a net income loss of $2.36 million. Consequently, the earnings per share (EPS) for the quarter settled at -$0.03, underscoring the ongoing challenges in translating top-line growth into bottom-line profitability during this fiscal segment.

Additional News

Recent market data highlights a notable shift in investor sentiment regarding Zevia PBC. Short interest in the company has decreased dramatically by 62.98% compared to the previous month, signaling improving investor confidence. Currently, only 1.09% of the float remains sold short, supported by a low short interest ratio of 0.36 days to cover, which is generally viewed as a healthy and acceptable level. In terms of corporate ownership, institutional investors hold a substantial 53.21% of the stock, suggesting strong market trust, while insiders retain 7.70%. However, insider activity has been exclusively negative; in the past three months, insiders sold $4,085,000 worth of stock while purchasing $0.00, indicating a lack of insider buying support. News sentiment for ZVIA has scored 0.96 over the last seven days, outperforming the 0.75 average for Consumer Staples companies, although search interest and watchlist additions remain relatively low. The company continues to pay no dividends, consistent with its growth-stage status.

Summary & Outlook

Zevia’s financial health is characterized by moderate top-line revenue of $46.09 million in Q1, yet hampered by persistent net losses of $2.36 million and negative EPS. While gross margins are stable, the path to profitability remains uncertain. The primary growth catalyst is the analyst consensus expectation of narrowing EPS losses to ($0.06) in 2026, paired with a high upside potential in the stock price based on current levels. However, risks include high valuation multiples (P/B >3) and significant insider selling. Overall, the outlook is neutral-to-cautiously bullish; while short interest reduction and improved news sentiment are positive indicators, the company must demonstrate tangible progress in converting revenue to net income to justify its valuation and sustain long-term growth prospects.